BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7887544)

  • 1. Pseudomyxoma peritonei: does a true mucolytic agent exist? In vitro and in vivo studies.
    Shyr YM; Su CH; Wang HC; Lo SS; Lui WY
    Am Surg; 1995 Mar; 61(3):265-70. PubMed ID: 7887544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hyperglycemia following intraperitoneal irrigation with 10% dextrose in a patient with pseudomyxoma peritonei.
    Roy WJ; Thomas BL; Horowitz IR
    Gynecol Oncol; 1997 May; 65(2):360-2. PubMed ID: 9159352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
    Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
    Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin secreted in pseudomyxoma peritonei.
    Pillai K; Akhter J; Chua TC; Morris DL
    J Surg Res; 2012 May; 174(2):e69-73. PubMed ID: 22261589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC2 is a molecular marker for pseudomyxoma peritonei.
    O'Connell JT; Hacker CM; Barsky SH
    Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case report of malignant pseudomyxoma peritonei treated by a new modality of intraperitoneal chemo-hyperthermia].
    Kishimoto S; Kameyama M; Kodama K; Nakamori S; Ohigashi H; Hiratsuka M; Sasaki Y; Ishikawa O; Kabuto T; Furukawa H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1703-6. PubMed ID: 8373254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process.
    Mohamed F; Gething S; Haiba M; Brun EA; Sugarbaker PH
    J Surg Oncol; 2004 Apr; 86(1):10-5. PubMed ID: 15048674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomyxoma peritonei syndrome of appendiceal origin: an overview.
    Brueggen C; Baird G; Meisheid A
    Clin J Oncol Nurs; 2007 Aug; 11(4):525-32. PubMed ID: 17723965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conservative treatment of pseudomyxoma peritonei].
    Machado MA; Rodrigues JG; Laurino RM; Garrido Júnior A; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(6):301-4. PubMed ID: 8029605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomyxoma peritonei: possible prevention of mucinous ascites by peritoneal lavage.
    Piver MS; Lele SB; Patsner B
    Obstet Gynecol; 1984 Sep; 64(3 Suppl):95S-96S. PubMed ID: 6472756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intraperitoneal irrigation for pseudomyxoma peritonei-a case of critical metabolic alkalosis precipitated by irrigation with 101 of sodium bicarbonate--].
    Shirasaki R; Yamasaki S; Wakamatsu M; Mori Y; Hirano H; Kaida T; Machino A
    Masui; 2013 May; 62(5):604-8. PubMed ID: 23772538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo model of pseudomyxoma peritonei for novel candidate drug discovery.
    Chua TC; Akther J; Yao P; Morris DL
    Anticancer Res; 2009 Oct; 29(10):4051-5. PubMed ID: 19846950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
    Prayson RA; Hart WR; Petras RE
    Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An analysis of pathologic features and prognostic factors of 10 cases with pseudomyxoma peritonei].
    Zhou X; Du X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):543-6. PubMed ID: 8556915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic difficulties in pseudomyxoma peritonei].
    Arendt J; Sieroń A; Biniszkiewicz T; Jagodziński L; Waniczek D
    Wiad Lek; 2003; 56(1-2):71-5. PubMed ID: 12901272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pseudomyxoma peritonei with two times--cytoreduction and hypertermic antiblastic peritoneal perfusion (HAPP).
    De Simone M; Scuderi S; Vaira M; Costamagna D; Barone R; Fiorentini G; Dentico P; Caponi A; Ciaccio B; Caponi C; Ferri L; Martini E; Cantini S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):25-8. PubMed ID: 16767902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transient hyperglycemia following intra-peritoneal irrigation with 5% glucose in a patient with pseudomyxoma peritonei].
    Mieda R; Aso C; Nishikawa K; Saito S; Goto F
    Masui; 2007 Aug; 56(8):959-61. PubMed ID: 17715692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
    Hsu KH; Chou CY; Chang YC
    Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of pseudomyxoma peritonei with a pancreatic cancer treated by the intraperitoneal administration of cisplatinum].
    Mitsuhashi T; Murata N; Sobajima J; Okada N; Suzuki T; Ishida H; Hashimoto D; Miura I; Itoyama S
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1670-3. PubMed ID: 11708005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of pseudomyxoma peritonei successfully treated with intra-peritoneal hyperthermia].
    Okugawa T; Yamada K; Futamura N; Ida M; Nishimura K; Nose Y; Uematsu A; Toyoda N
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1345-8. PubMed ID: 8258736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.